Migraine Therapy: Development and Testing of a Patient Preference Questionnaire
Version of Record online: 12 JUN 2003
Headache: The Journal of Head and Face Pain
Volume 38, Issue 8, pages 602–607, September 1998
How to Cite
Caro, G., Caro, J. J., O'Brien, J. A., Anton, S. and Jackson, J. (1998), Migraine Therapy: Development and Testing of a Patient Preference Questionnaire. Headache: The Journal of Head and Face Pain, 38: 602–607. doi: 10.1046/j.1526-4610.1998.3808602.x
- Issue online: 12 JUN 2003
- Version of Record online: 12 JUN 2003
- Accepted for publication February 6, 1998.
- Cited By
- patient preference;
- efficacy measures
Objectives.—To develop and test a patient preference questionnaire in migraine.
Methods.—A user-friendly, self-administered questionnaire was developed to assess the relative importance of aspects of migraine therapy to patients. It was tested in a convenience sample of 66 migraineurs. The questionnaire has five sections: patient preference, migraine history, demographics, usual behavior during an attack, and migraine impact on cognition and functionality. It employs a special reverse-ranking technique to quantify preferences.
Results.—Sixty-six migraineurs participated: 86% were women, 53% had not consulted their doctor about migraine in the previous year; and only 51% took prescribed medication, the majority (52%) at the start of a migraine. “A medication that can be taken any time during a migraine attack” was ranked most important by 20% of the migraineurs, one that decreases pain from the unbearable level in 30 minutes by 17%, and one that relieves pain completely within 2 hours by 15%. Not being able to think or concentrate with severe symptoms was reported by 71%. Optional activities were impeded by migraine in 83% of subjects, but required activities in only 60%.
Conclusions.—The patient preference questionnaire is readily completed by subjects and reveals that the dimensions of relief preferred by patients can be addressed by a self-report questionnaire.